Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Feb 15, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sage Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 13
| |||||||
Sage Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Aug 4
| |||||||
Karyopharm Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
May 24
| |||||||
Sage Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 13
| |||||||
Sage Therapeutics, Inc.
| 14.5K |
$34.48 | $500,022.35 | +44.70% | 46.94K |
Nov 10
| |||||||
Karyopharm Therapeutics Inc.
| 7.58K |
$1.49 | $11,250.36 | +125.64% | 13.61K |
Aug 11
| |||||||
Karyopharm Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
May 19
| |||||||
Sage Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 11
| |||||||
Sage Therapeutics, Inc.
| 23.64K |
$43.15 | $1,020,054.18 | +268.64% | 32.44K |
Aug 5
| |||||||
Sage Therapeutics, Inc.
| 8.8K |
$56.32 | $495,627.44 |
∞
| 8.8K |
Jun 16
| |||||||
Acorda Therapeutics Inc
|
0
|
—
|
—
|
—
|
0
|
Jun 2
| |||||||
Karyopharm Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
May 21
| |||||||
Sage Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 4
| |||||||
Bcls Acquisition Corp.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Sage Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Oct 1
| |||||||
Sage Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Alnylam Pharmaceuticals, Inc.
| -155.00 |
$66.19 | -$5,080,590.29 | -0.11% | 135.91K |
Jul 16 - Sep 9
|
Scheduled
| ||||||
Alnylam Pharmaceuticals, Inc.
| 4.93K |
$70.95 | $349,871.48 | +7.92% | 67.17K |
Aug 10
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
$84.57 | -$3,358,675.25 |
—
| 62.24K |
Jul 7
|
Scheduled
| ||||||
Acorda Therapeutics Inc
|
0
|
—
|
—
|
—
|
0
|
Jun 15
| |||||||
Karyopharm Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
May 21
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
$79.57 | -$3,136,025.25 |
—
| 62.24K |
May 6
|
Scheduled
| ||||||
Alnylam Pharmaceuticals, Inc.
| 3.75K |
$104.82 | -$174,320.85 | +6.42% | 62.24K |
Apr 7
| |||||||
Karyopharm Therapeutics Inc.
| 3.03K |
$0.03 | $99.99 | +101.00% | 6.03K |
Mar 13
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 26
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Dec 23
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Nov 22
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
$53.21 | -$4,333,640.28 |
—
| 61.97K |
Oct 22 - Oct 23
|
Scheduled
| ||||||
Alnylam Pharmaceuticals, Inc.
| 46 |
—
|
—
| +1.56% | 3K |
Jul 11 - Aug 6
| |||||||
Acorda Therapeutics Inc
|
0
|
—
|
—
|
—
|
0
|
Jun 19
| |||||||
Alnylam Pharmaceuticals, Inc.
| 73 |
—
|
—
| +2.53% | 2.96K |
Oct 18 - Jun 5
| |||||||
Karyopharm Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 6
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 28
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Sep 27
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Aug 21
| |||||||
Alnylam Pharmaceuticals, Inc.
| 74 |
—
|
—
| +0.11% | 64.85K |
Jan 17 - Aug 10
| |||||||
Acorda Therapeutics Inc
|
0
|
—
|
—
|
—
|
0
|
Jun 27
| |||||||
Karyopharm Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 19
| |||||||
Acorda Therapeutics Inc
| 1.27K |
$21.63 | $6.30 |
∞
| 1.27K |
May 21
| |||||||
Alnylam Pharmaceuticals, Inc.
| -38.46K |
$143.10 | -$5,503,735.75 | -38.30% | 61.97K |
Mar 14
|
Scheduled
| ||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.